Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of DVS SR in Diabetic Peripheral Neuropathy
NCT01050218Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jul 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desvenlafaxine in diabetic peripheral neuropathy (DPN), sponsored by Pfizer. Started Jul 2006; status: terminated.
02
Drugs
desvenlafaxine
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01050218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050218.